Fetal anomaly screening is a vital part of prenatal care, aimed at assessing the health and development of your baby during pregnancy. This screening typically involves a combination of maternal blood tests and detailed ultrasound scans to detect potential chromosomal abnormalities, such as Down syndrome (Trisomy 21), Trisomy 18, and neural tube defects. By identifying these conditions early, we can provide appropriate counseling and management options to support you throughout your pregnancy. 

The screening process usually occurs between 11 and 22 weeks of gestation. Maternal serum screening measures specific substances in the mother’s blood that can indicate an increased risk of certain fetal conditions. If the results suggest a higher risk, further diagnostic procedures like amniocentesis or chorionic villus sampling (CVS) may be offered to confirm the diagnosis. Early detection allows for informed decision-making and better preparation for any necessary medical care or interventions.

At Klinik Pakar Wanita Aymira, we prioritize your comfort and understanding throughout the screening process. Our experienced healthcare professionals will guide you through each step, ensuring you receive comprehensive information and support. We are committed to providing personalized care that respects your values and choices, helping you make informed decisions for the well-being of both you and your baby.